Beitrag

04.11.2026

Welcome to M3: New Research Group AG Plum Focuses on Translational Gastrointestinal Oncology and Metabolism

We are delighted to welcome AG Plum – Translational Gastrointestinal Oncology and Metabolism, led by PD Dr. med. Patrick S. Plum, as a new research group at the M3 Research Center since October 2026. The group’s research activities and scientific focus were introduced during the M3 Progress Report on 4 November 2026. Its overarching goal is to build translational bridges between tumor biology, treatment response and metabolic disease, connecting clinical challenges with molecular research.

The group’s research focuses on three interconnected areas:

Tumor microenvironment in upper gastrointestinal cancers: Using single-cell sequencing, FACS-sorted  and spatial transcriptomics, the group investigates cellular heterogeneity and interactions within upper GI tumors. The aim is to better understand the role of the tumor microenvironment in cancer development and treatment response.

Mechanisms of treatment resistance: A second focus is on understanding why patients respond differently to multimodal cancer therapies. Patient-derived organoids and tissue-slice models are used to investigate treatment resistance and identify potential therapeutic targets. One key project examines the heterogeneous response to perioperative chemo-immunotherapy in esophageal and gastric adenocarcinomas.

Metabolic diseases: The third research area centers on the DECODE-MD project. It aims to identify clinical and molecular biomarkers that predict outcomes following bariatric surgery. A longitudinal biosample pipeline and multi-omics analyses will help link individual patient trajectories to underlying molecular mechanisms and support more personalized treatment strategies.


By combining clinical cohorts, advanced molecular profiling and functional experimental models, AG Plum aims to translate biological insights into clinically relevant biomarkers and new therapeutic approaches.

We wish Patrick Plum and all members of AG Plum every success with their upcoming projects. We look forward to exciting scientific collaborations and a fruitful exchange with the other research groups and teams across M3!

Read more about the AG and it´s research focus: https://www.medizin.uni-tuebingen.de/de/das-klinikum/einrichtungen/zentren/m3/translational-gastrointestinal-oncology-and-metabolism